Leading the Way in Life Science Technologies

GEN Exclusives

More »

McGill University - Related Content

  • Page 1 of 1 (2 items) 1 
  • GEN Podcasts
  • EARLY ALZHEIMER'S DIAGNOSIS AND POTENTIAL THERAPIES
    - Interview with Hemant K. Paudel, Ph.D., Associate Professor, Department of Neurology and Neurosurgery, McGill University, and Project Director, Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis-Jewish General Hospital
  • RESEARCH CASTS DOUBT ON FREE RADICAL ROLE IN AGING
    - Interview with Siegfried Hekimi, Ph.D., Strathcona Chair of Zoology and Robert Archibald & Catherine Louise Campbell Chair in Developmental Biology, McGill University
  • Page 1 of 1 (2 items) 1 

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »